Inflammation & Bone
Live Webinar: 18 February, 3.30pm CET
Date & Time: 18 February 2020, 3.30pm CET
Featuring Georg Schett and moderated by Thomas Funck-Brentano
Costs: Live webinar is free for ECTS members and non-members, but a registration is required. Recordings are accessible to ECTS members only.
Format:
- 5 min welcome & introductions
- 35 min presentation
- 20 min Q&A
About the speaker
Georg Schett is professor of Internal Medicine and since 2006 head of the Department of Medicine 3 – Rheumatology and Immunology – of the Friedrich-Alexander University Erlangen-Nürnberg in Germany. He graduated from the University of Innsbruck (Austria) in 1994. After his dissertation from medical school, he worked as scientist at the Institute of BioMedical Aging Research of the Austrian Academy of Science in Innsbruck. In 1996, he joined the Department of Medicine at the University of Vienna, where he completed his postgraduate training in Internal Medicine and subsequently in Rheumatology. In 2003 he was promoted to professor of Internal Medicine. Before taking up his position as chair of the Department of Medicine 3, he worked as a scientist in the United States for one year.
Moderated by Thomas Funk-Brentano
Thomas Funck-Brentano is a clinical rheumatologist with a preclinical background. He is a member of the ECTS Academy since 2016. He trained in University Paris Diderot and defendend his PhD (supervised by Pr Martine Cohen-Solal) in 2013 on the role of the Wnt signaling pathway in the subchondral bone in preclinical models of osteoarthritis. He then was assistant professor in the department of Rheumatology in Hôpital Lariboisière in Paris (2012-2016) were he got particularly interested in managing bone diseases, such as osteoporosis and rare bone diseases. He has recently moved to the University of Gothenburg (Sweden) in Pr Claes Ohlsson’s group to enhance his skills in translational research. His project on the functional studies of NOTUM as a regulator of cortical bone mass was granted by Sweden’s Innovation Agency Vinnova for a two-year fellowship. He is also involved in clinical research projects on the link between bone and cardiometabolic diseases and osteoarthritis using various large databases.
